Starting from the observation that edema, vessel dilatation, and inflammatory cells infiltration are the histopathological elements characteristic of nasal polyposis, the authors have carried out a study on a group of patients suffering from relapsing polyposis. The efficacy of furosemide for the prevention of relapses of nasal polyposis in a 4 year follow up has been pointed out. This diuretic given by nasal inhalation proved to be able to protect the nasal mucosa against provocation with ultrasonic nebulized distilled water and to prevent the recurrence or relapse of nasal polyposis after surgery.
LaroccaL., MaggianoN., CapelliA.Immunopathology of nasal polyps: An immunohistochemical approach.Ann Allergy63: 508–515, 1989.
5.
PetrusonB., HanssenH., PetrusonK.Insulin-like growth factor is a possible pathogenetic mechanism in nasal polyps?Acta Otolaryngol (Stockholm)106: 156–160, 1988.
6.
BiancoS., PieroniM.G., RefiniM., RottoliL., SestiniP.Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions.Am Rev Resp Dis321: 1069–1070, 1989.
7.
AllegraL., BiancoS.Nonspecific broncho-reactivity obtained with an ultrasonic aerosol of distilled water.Europ J Resp Dis (Suppl. 106), 41–60, 1980.
8.
HappR., ChristyJ., BewtraA., NariN., TownleyR.Incorporation and analysis of ultrasonically nebulized distilled water challenges in an epidemiologic study of asthma and bronchial reactivity.Am Allergy60: 129–133, 1988.
9.
JacksonA.C., ButlerP., MillerE.J.Airway geometry by analysis of acoustic pulse response measurements.J Appl Physiol Meas43: 523–528, 1977.
10.
GuytonA.G.Trattato di Fisiologia Medica Ed. Ital.Curatolo E. Piccin Padova, 1978.
11.
NewmanS., PellowP., ClarkeS.Droplet size distributions of nebulized aerosol for inhalation therapy.Clin Physiol Meas7(2): 139–146, 1986.
SettipaneG.A., ChafeeF.H.Nasal polyps in asthma and rhinitis.J Allergy Clin Immunol59(13): 17–21, 1977.
14.
TogiasA., NaclerioR.M., ProudD.Challenge with cold, dry air results in release of inflammatory mediators possible mast cell involvement.J Clin Invest76: 1375–1381, 1985.
15.
RichersonH.B., SeebohmP.M.Nasal airway response to exercise.J Allergy41(5): 269–286, 1968.
16.
SakethodK., KaplanI., SacknerM.Effect of exercise on nasal mucous velocity and nasal airflow resistance in normal subjects.J Appl Physiol Environ Exercise Phys46(2): 369–371, 1979.
17.
SyabbaloN.C., BungaardA., WiddicombeJ.G.Effects of exercise on nasal airflow resistance in healthy subjects and in patients with asthma and rhinitis.Bull Env Physiopathol Respir21: 507–513, 1985.
18.
DevillierP., DessangesJ., RokotosihanakaF.Nasal response to substance P and methacoline in subjects with and without allergic rhinitis.Eur Resp J1(4): 356–361, 1988.
19.
GhersonG., MoscatoG., VidiI.Nonspecific nasal reactivity. A proposed method of study.Eur J Resp Dis69(1): 24–28, 1986.
20.
PolosaR., LauL.K., HolgateS.T.Inhibition of adenosine 5’ monophosphate and methacholine-induced bronchoconstriction in asthma by inhaled furosemide.Eur Respir J3(6): 665–672, 1990.
21.
AndersonS., HeW., TempleD.M.Inhibition by furosemide of inflammatory mediators from lung fragments.N Engl J Med124–131, 1991.
22.
BernsteinJ.M., CroppG.A., NathansonI., YankaskasJ.R.Bioelectric properties of cultured nasal polyp and turbinate epithelial cells.Am J Rhinol4: 2–45, 1990.
